secwatch.observer — SEC 8-K summary
======================================

Issuer:     WINDTREE THERAPEUTICS INC /DE/ (WINT)
CIK:        0000946486
Form:       8-K
Filed at:   2023-04-24T23:59:59+00:00
Accession:  0001437749-23-010927
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Windtree Therapeutics closes public offering of common stock and warrants for net proceeds of $10.8M
--------------------------------------------------------------------------------

- Closed public offering of 3,686,006 shares of common stock and warrants for additional 3,686,006 shares at $2.93 per unit.
- Net proceeds of approximately $10.8M after underwriting discounts and expenses; $3.5M earmarked for istaroxime Phase 2 cardiogenic shock trial.
- Underwriter's option exercised in full for additional 552,900 shares and warrants.
- Warrants immediately exercisable at $2.93, expire in 5 years, subject to 4.99% (or 9.99%) beneficial ownership limitation.
- 75-day lock-up on further equity issuances; common warrants not listed on any exchange.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946486/000143774923010927/0001437749-23-010927-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946486/000143774923010927/wint20230421_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-010927

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer